News | Artificial Intelligence | August 10, 2023

Partnership makes AI4MedImaging’s AI4CMR solution available on the Blackford Platform 

Partnership makes AI4MedImaging’s AI4CMR solution available on the Blackford Platform

August 10, 2023 — Blackford, the pioneering strategic imaging AI platform and solutions provider, and AI4MedImaging, a cardiac MRI solution provider announce a partnership to make the AI4CMR solution available on the Blackford Platform. AI4CMR will enable Blackford customers to automatically segment and quantify cardiac MRI measurements. 

"Blackford’s mission is to deliver AI that provides value to healthcare providers to increase efficiency and improves patient outcomes,” said Blackford CEO Ben Panter. “We are excited to increase our cardiac MRI solution offering on the Blackford Platform with AI4MedImaging.” 

AI4CMR uses artificial intelligence to calculate, quantify, and analyse the left and right ventricle within 2 minutes, and produces a structured report to be extracted to any reporting system. It also provides a triage functionality for wall motion detection (this functionality is CE marked and FDA-pending). 

“AI4MedImaging is thrilled to partner with Blackford and contribute to the democratization of Cardiac Magnetic Resonance. With AI4CMR, the first cardiac AI to receive CE and FDA approval, analysis is fast, accurate, made-easy and available at any location due to the web-based cloud technology used,” said AI4MedImaging’s CEO and MD Vítor Pereira. 

For more information: www.blackfordanalysis.com 


Related Content

News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | ASE

May 4, 2026 — The American Society of Echocardiography (ASE) has released a new guideline that provides guidance for ...

Time May 05, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

April 27, 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
Subscribe Now